Cargando…
Novel homozygous inactivating mutation of the calcium-sensing receptor gene in neonatal severe hyperparathyroidism responding to cinacalcet therapy: A case report and literature review
RATIONALE: Calcium-sensing receptor (CaSR) mutations can cause life-threatening neonatal severe hyperparathyroidism (NSHPT). The medical management of NSHPT is often challenging and complex. Here, we present a case of NSHPT caused by a novel homozygous CaSR mutation. PATIENT CONCERNS: A Chinese fema...
Autores principales: | Sun, Xiaomei, Huang, Liang, Wu, Jin, Tao, Yuhong, Yang, Fan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250440/ https://www.ncbi.nlm.nih.gov/pubmed/30407334 http://dx.doi.org/10.1097/MD.0000000000013128 |
Ejemplares similares
-
The efficiency of cinacalcet treatment in delaying parathyroidectomy in a case with neonatal severe hyperparathyroidism caused by homozygous mutation in the CASR gene
por: Çömlek, Fatma Özgüç, et al.
Publicado: (2022) -
Neonatal severe hyperparathyroidism due to a homozygous mutation of calcium-sensing receptor; a challenging case
por: Hashim, Raihana, et al.
Publicado: (2019) -
Successful Early Treatment of Severe Neonatal Hyperparathyroidism With Cinacalcet
por: Thakkar, Keya, et al.
Publicado: (2021) -
Successful treatment of neonatal severe hyperparathyroidism with cinacalcet in two patients
por: Fisher, Marisa M, et al.
Publicado: (2015) -
Cinacalcet Treatment of Primary Hyperparathyroidism
por: Rothe, H. M., et al.
Publicado: (2011)